Clinical Trial Update: A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 5 mg versus 20 mg desloratadine for the development of cold urticaria lesions has completed. The study pertains to Acquired Cold Urticar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Cold Urticaria

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Acquired Cold Urticaria | Phase 4 | Status: COMPLETED